Why are Braskem's controlling stakeholders opposed to selling the U.S. assets?

The parties vying for control of Braskem, including businessman Nelson Tanure and private equity firm IG4 Capital, see the U.S. holdings as strategically important and crucial to the company's future.

How will the battle for Braskem's control impact the fate of its U.S. assets?

The outcome of the power struggle for Braskem's future is expected to determine whether the American facilities are sold or retained by the company.

Home / Business and Economy / Rivals Resist Braskem's U.S. Asset Sale Amid Control Battle

Rivals Resist Braskem's U.S. Asset Sale Amid Control Battle

Q: What is Unipar's plan for Braskem's U.S. assets?

Unipar is in talks to acquire Braskem's polypropylene plants in Texas, Pennsylvania, and West Virginia for around $1 billion.

8 Aug

•

Summary

Unipar in talks to buy Braskem's U.S. plants for $1 billion
Braskem's controlling stakeholders oppose selling U.S. assets
Acquisition battle for Braskem's future control ongoing

Rivals Resist Braskem's U.S. Asset Sale Amid Control Battle

As of August 8, 2025, the future of Brazilian petrochemical producer Braskem's U.S. assets has become a point of contention amid an ongoing battle for control of the company.

Unipar, a Brazilian chemical firm, is currently in negotiations to acquire Braskem's polypropylene plants in Texas, Pennsylvania, and West Virginia for around $1 billion. However, the parties jockeying to assume a controlling stake in Braskem are reportedly opposed to selling off these American operations.

Brazilian businessman Nelson Tanure, who is in exclusive talks to acquire a controlling interest in Braskem, is said to be against the idea of divesting the U.S. assets. Similarly, private equity firm IG4 Capital, which has a rival plan to take control of Braskem, would likely oppose such a sale without a comprehensive plan for the company's future.

According to sources, the U.S. holdings are seen as strategically important by those vying for Braskem's control. A sale would also run counter to the company's stated strategic objectives. Braskem's CEO has already denied any interest in selling the American facilities.

The battle for Braskem's future is expected to intensify in the coming weeks as the exclusive negotiation period for Tanure's acquisition bid expires. The outcome of this power struggle will likely determine the fate of Braskem's prized U.S. assets.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.